Hengrui Pharma and partner Kailera have joined the ranks of companies with clinical data in hand for an oral drug for weight loss, reporting weight loss of up to 12.1% in a phase 2 trial with their ...

AstraZeneca is already deeply embedded in China's pharma sector, and is hungry for more, pledging $15 billion to an investment programme in the country and signing a mammoth licensing deal with Hong ...

US healthcare giant Johnson & Johnson has said that after a "catapult year" in 2025, it is on course to report around $100 billion in sales this year for the first time. The prediction came as J&J ...

Earlier this week, NHS England said that production problems at German company Heraeus Medical – which is the main supplier ...

Texas Attorney General Ken Paxton has filed a lawsuit against Sanofi, claiming the company bribed doctors to prescribe its medicines, in the state's latest broadside against pharma groups.

Daiichi Sankyo has named John Tsai as its new chief medical officer (CMO), replacing Ken Takeshita, who is stepping down after five years in the role on 1st April.

Almost 30,000 people in England with chronic obstructive pulmonary disease (COPD) could soon have access to a biologic treatment, Sanofi and Regeneron's Dupixent, after it was recommended for use by ...

The 7th Dermatology Drug Development Summit Europe is a premier three-day industry event designed for senior leaders, clinical scientists, regulatory experts and commercial strategists shaping the ...

The agreement – which has been valued at up to $1.15 billion – is the strongest signal yet of Hims & Hers' aspirations to grow into a global health player, with the addition of Eucalyptus giving it a ...

The FDA plans to adopt a new policy that will do away with the default requirement to base regulatory filings for new medicines on two pivotal trials, according to Commissioner Marty Makary.

The new NICE guidance recommends that most people should now be offered metformin along with an SGLT-2 inhibitor from the start, while also advising that they get a slow-release formulation of ...

The long months without stable leadership at the CDC in the US look set to continue, as the Trump administration confirms that NIH Director Jay Bhattacharya will step in as acting director of the ...